Rasmussen MH - Search Results

1

Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial.

Miller BS, Blair JC, Rasmussen MH, Maniatis A, Kildemoes RJ, Mori J, Polak M, Bang RB, Böttcher V, Stagi S, Horikawa R. Miller BS, et al. Among authors: rasmussen mh. J Clin Endocrinol Metab. 2022 Nov 25;107(12):3378-3388. doi: 10.1210/clinem/dgac513. J Clin Endocrinol Metab. 2022. PMID: 36062966 Free PMC article. Clinical Trial.

2

Pegylated long-acting human growth hormone is well-tolerated in healthy subjects and possesses a potential once-weekly pharmacokinetic and pharmacodynamic treatment profile.

Rasmussen MH, Bysted BV, Anderson TW, Klitgaard T, Madsen J. Rasmussen MH, et al. J Clin Endocrinol Metab. 2010 Jul;95(7):3411-7. doi: 10.1210/jc.2009-2813. Epub 2010 Apr 28. J Clin Endocrinol Metab. 2010. PMID: 20427496 Clinical Trial.

3

Multiple doses of pegylated long-acting growth hormone are well tolerated in healthy male volunteers and possess a potential once-weekly treatment profile.

Rasmussen MH, Jensen L, Anderson TW, Klitgaard T, Madsen J. Rasmussen MH, et al. Clin Endocrinol (Oxf). 2010 Dec;73(6):769-76. doi: 10.1111/j.1365-2265.2010.03863.x. Clin Endocrinol (Oxf). 2010. PMID: 20718773 Clinical Trial.

4

Pegylated long-acting human growth hormone possesses a promising once-weekly treatment profile, and multiple dosing is well tolerated in adult patients with growth hormone deficiency.

Søndergaard E, Klose M, Hansen M, Hansen BS, Andersen M, Feldt-Rasmussen U, Laursen T, Rasmussen MH, Christiansen JS. Søndergaard E, et al. Among authors: rasmussen mh. J Clin Endocrinol Metab. 2011 Mar;96(3):681-8. doi: 10.1210/jc.2010-1931. Epub 2010 Dec 22. J Clin Endocrinol Metab. 2011. PMID: 21177789 Clinical Trial.

5

Assessing the impact of growth hormone deficiency and treatment in adults: development of a new disease-specific measure.

Brod M, Højbjerre L, Adalsteinsson JE, Rasmussen MH. Brod M, et al. Among authors: rasmussen mh. J Clin Endocrinol Metab. 2014 Apr;99(4):1204-12. doi: 10.1210/jc.2013-3438. Epub 2014 Jan 17. J Clin Endocrinol Metab. 2014. PMID: 24438372

6

A reversible albumin-binding growth hormone derivative is well tolerated and possesses a potential once-weekly treatment profile.

Rasmussen MH, Olsen MW, Alifrangis L, Klim S, Suntum M. Rasmussen MH, et al. J Clin Endocrinol Metab. 2014 Oct;99(10):E1819-29. doi: 10.1210/jc.2014-1702. Epub 2014 Jul 11. J Clin Endocrinol Metab. 2014. PMID: 25013997 Clinical Trial.

7

Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency.

Rasmussen MH, Janukonyté J, Klose M, Marina D, Tanvig M, Nielsen LF, Höybye C, Andersen M, Feldt-Rasmussen U, Christiansen JS. Rasmussen MH, et al. J Clin Endocrinol Metab. 2016 Mar;101(3):988-98. doi: 10.1210/jc.2015-1991. Epub 2016 Jan 4. J Clin Endocrinol Metab. 2016. PMID: 26727076 Free PMC article. Clinical Trial.

8

Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.

Battelino T, Rasmussen MH, De Schepper J, Zuckerman-Levin N, Gucev Z, Sävendahl L; NN8640-4042 Study Group. Battelino T, et al. Among authors: rasmussen mh. Clin Endocrinol (Oxf). 2017 Oct;87(4):350-358. doi: 10.1111/cen.13409. Epub 2017 Aug 8. Clin Endocrinol (Oxf). 2017. PMID: 28656605 Clinical Trial.

9

Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial.

Johannsson G, Feldt-Rasmussen U, Håkonsson IH, Biering H, Rodien P, Tahara S, Toogood A, Rasmussen MH; REAL 2 Study Group. Johannsson G, et al. Among authors: rasmussen mh. Eur J Endocrinol. 2018 May;178(5):491-499. doi: 10.1530/EJE-17-1073. Epub 2018 Mar 2. Eur J Endocrinol. 2018. PMID: 29500310 Free PMC article. Clinical Trial.

10

Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.

Kildemoes RJ, Hollensen C, Biller BMK, Johannsson G, Takahashi Y, Rasmussen MH. Kildemoes RJ, et al. Among authors: rasmussen mh. Eur J Endocrinol. 2022 May 16;187(1):27-38. doi: 10.1530/EJE-21-1167. Eur J Endocrinol. 2022. PMID: 35521713 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page